肺癌分子靶点治疗的研究进展(7)
12Azzoli CG, Krug LM, Miller VA, et al. rastuzumab in the treatment of non-small cell lung cancer. Semin Oncol,2002,29(1 Suppl 4):59-65
13Kakeya, H, Onose, R, Lui, PCC, et al.Inhibition of cyclin D1 expression and phosphorylation of retinoblastoma protein by phosmidosine a nucleotide antibiotic. Cancer Res,1998,58(4):704-710
14Pellizzaro C, Coradini D, Daniotti A, et al. Modulation of cell cycle-related protein expression by sodium butyrate in human non-small cell lung cancer cell lines. Int J Cancer,2001,91(5):654-657
15Ohmori T, Podack ER, Nishio K, et al. Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2. Biochem Biophys Res Commun, 1993, 192(1):30-36
16Frankel AE, Schuster MW, Jurcic JG. Novel therapeutics for chemotherapy-resistant acute myeloid leukaemia. BioDrugs, 2001,15(1):55-71
17Rusch, V, Klimstra, D, Linkov, I, et al. Aberrant expression of p53 and the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development. Cancer Res,1995,55(6):1365-1372
18Fujiwara, T, Grimm, EA, Mukhopadhyay, T, et al. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res,1993,53:4029-4123
19Fujiwara, T, Grimm, EA, Mukhopadhyay, T, et al. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res,1994, 54(9):2287-2291
20Roth, JA, Nguyen, P, Lawrence, DD, et al . Retroviral-mediated wild type p53 gene transfer to tumors of patients with lung cancer. Nat Med ,1996,2(9):985-991
21Swisher SG, Roth JA, Carbone DP. Genetic and immunologic therapies for lung cancer. : Semin Oncol, 2002,29(1 Suppl 4):95-101
22Schauer, IE, Siriwardana, S, Langan, TA, et al. Cyclin D1 overexpression vs retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer. Proc Natl Acad Sci USA USA,1994,91:7827-7831
23Kelly, MJ, Nakagawa, K, Steinberg, SM, et al. Differentiated inactivation of CDKN2 and Rb proteins in non-small cell and small cell lung cancer cell lines. J Natl Cancer Inst ,1995,87(10):756-761, 百拇医药(乔贵宾 吴一龙)
13Kakeya, H, Onose, R, Lui, PCC, et al.Inhibition of cyclin D1 expression and phosphorylation of retinoblastoma protein by phosmidosine a nucleotide antibiotic. Cancer Res,1998,58(4):704-710
14Pellizzaro C, Coradini D, Daniotti A, et al. Modulation of cell cycle-related protein expression by sodium butyrate in human non-small cell lung cancer cell lines. Int J Cancer,2001,91(5):654-657
15Ohmori T, Podack ER, Nishio K, et al. Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by bcl-2. Biochem Biophys Res Commun, 1993, 192(1):30-36
16Frankel AE, Schuster MW, Jurcic JG. Novel therapeutics for chemotherapy-resistant acute myeloid leukaemia. BioDrugs, 2001,15(1):55-71
17Rusch, V, Klimstra, D, Linkov, I, et al. Aberrant expression of p53 and the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development. Cancer Res,1995,55(6):1365-1372
18Fujiwara, T, Grimm, EA, Mukhopadhyay, T, et al. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res,1993,53:4029-4123
19Fujiwara, T, Grimm, EA, Mukhopadhyay, T, et al. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res,1994, 54(9):2287-2291
20Roth, JA, Nguyen, P, Lawrence, DD, et al . Retroviral-mediated wild type p53 gene transfer to tumors of patients with lung cancer. Nat Med ,1996,2(9):985-991
21Swisher SG, Roth JA, Carbone DP. Genetic and immunologic therapies for lung cancer. : Semin Oncol, 2002,29(1 Suppl 4):95-101
22Schauer, IE, Siriwardana, S, Langan, TA, et al. Cyclin D1 overexpression vs retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer. Proc Natl Acad Sci USA USA,1994,91:7827-7831
23Kelly, MJ, Nakagawa, K, Steinberg, SM, et al. Differentiated inactivation of CDKN2 and Rb proteins in non-small cell and small cell lung cancer cell lines. J Natl Cancer Inst ,1995,87(10):756-761, 百拇医药(乔贵宾 吴一龙)